Guru Ownership Trend
Guru Analysis for Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $82.7 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bearish. This is evidenced by a $54.76 M net outflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 249.4%. Conversely, Jefferies Group reduced exposure by 26.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Cogent Biosciences, Inc. (COGT)
Major holders include Steven Cohen ($54.3 M), Renaissance Technologies (RenTech) ($27.18 M), Cliff Asness ($7.31 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.53 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $54.76 M, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited COGT. The total reported sell value was $85.09 M.
Yes, 0 managers opened new positions in COGT, and 4 increased their existing holdings. The total reported buy value was $30.33 M.